Document is current

Article History

Received: 9 July 2024

Accepted: 25 November 2024

First Online: 3 December 2024

Declarations

:

: Author Ke-Wei Zhu was employed by GuangZhou BaiYunShan Pharmaceutical Holdings CO.,LTD. BaiYunShan Pharmaceutical General Factory, Guangzhou, China. Author Zhe Yang was employed by the North China Medical Health Group Xingtai General Hospital, Xingtai, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

: This study was performed in line with the principles of the Declaration of Helsinki and other relevant guidelines and regulations. Ethics approval was obtained from the independent medical ethics committee of the hospital, and signed informed consent was waived due to the non-interventional and observational design. The waiver of signed informed consent and the study protocol were also approved by the independent medical ethics committee of the hospital (Table 1). Verbal informed consent was obtained from each patient with COVID-19.

: Signed informed consent was waived due to the non-interventional and observational design. The waiver of signed informed consent and the study protocol were also approved by the independent medical ethics committee of the hospital (Table 1). Verbal informed consent was obtained from each patient with COVID-19.